Medications and Dental Treatment: What Patients Need to Know Before Their Procedure

Medications and Dental Treatment What Patients Need to Know Before Their Procedure

The link between medications and dental treatment is easy to overlook. A tablet you take every morning for your heart, a twice-yearly injection for your bones, or a weekly diabetes pen can change how a dentist plans an extraction, an implant, or a bone graft. Most of the time the change is small: a different appointment time, a firmer plan for controlling bleeding, a different painkiller. Occasionally it is large enough that your own physician needs to be part of the conversation before surgery is scheduled.

This guide is written for international patients considering dental implants, extractions, bone grafts, or other oral surgery in Bangkok. It explains in plain English how common medicines affect dental planning, where the major dental and medical guidelines agree, and where they genuinely disagree. It does not replace advice from your dentist or your prescribing doctor, and it does not give dosing or scheduling instructions, because those depend on you.

Dental teams think about medications through six practical effects:

  • Bleeding: how easily a surgical site bleeds and how long it takes to stop.
  • Clotting risk: what could happen if a blood thinner were paused, such as a stroke or a blocked stent.
  • Infection and immunity: how well the body fights infection and heals a wound.
  • Bone and jaw healing: how some bone medicines change the way the jaw responds to surgery.
  • Blood sugar and fasting: what happens when meals are delayed or sedation is planned.
  • Drug interactions: how local anesthetic, antibiotics, and pain medicine combine with what you already take.

One rule applies to every section below. Do not stop, delay, reduce, or swap a prescribed medicine on your own because of a dental appointment. Many of these drugs protect you from a stroke, a heart attack, a fracture, or a flare of disease. Any change should be decided by your dentist and the clinician who prescribed the drug, together, with your records in front of them. General preparation for surgery, such as nutrition, sleep, and logistics, is covered separately in our guide to preparing your body for major dental surgery. This article stays focused on the medicines.

It also helps to separate routine dentistry from major surgery. An examination, a cleaning, a filling, or a crown rarely changes the picture. A single simple extraction usually changes it a little. Multiple extractions, grafting, a sinus lift, or full-arch implant surgery can change it a lot. Keep that spectrum in mind as you read.

BLOOD THINNERS AND DENTAL PROCEDURES

Blood thinners and dental procedures

Can you have a tooth extracted or an implant placed while taking blood thinners? Often, yes. The American Dental Association (ADA) states that for most patients it is not necessary to alter anticoagulant or antiplatelet therapy before dental intervention, and that bleeding can usually be handled with local measures at the surgical site. The harder question is how large the planned surgery is, not simply whether you take a blood thinner.

Anticoagulants versus antiplatelet drugs

“Blood thinner” is a friendly phrase, but it covers two different families of medicine, and dentists treat them differently.

Anticoagulants act on the clotting cascade, the chain of chemical steps that builds a stable clot. Warfarin reduces the activity of vitamin K-dependent clotting factors. Dabigatran blocks thrombin, while apixaban, rivaroxaban, and edoxaban block factor Xa, according to a review in the Journal of the Canadian Dental Association.

Antiplatelet drugs work on a different pathway. They stop platelets from clumping together at the start of clot formation. Aspirin, clopidogrel, ticagrelor, and prasugrel are the common examples.

The distinction matters in practice. Warfarin is monitored with a blood test called the INR. Newer anticoagulants are not. And antiplatelet drugs, especially after a coronary stent, can be dangerous to interrupt.

Warfarin and INR: what number is acceptable for dental surgery?

INR (international normalized ratio) measures how long your blood takes to clot. A person not taking warfarin has an INR near 1. People on warfarin are usually kept in a higher target range set by their doctor.

The Scottish Dental Clinical Effectiveness Programme (SDCEP) gives the most operational guidance. It recommends checking the INR ideally within 24 hours before an invasive procedure, or up to 72 hours before if your anticoagulation has been stable. If the INR is below 4, treatment can generally go ahead without interrupting warfarin. If it is 4 or above, invasive treatment should be delayed, or the patient referred if the problem is urgent.

Other sources are more conservative, and this is a genuine difference. The ADA’s page notes that some reviews support continuing warfarin when the INR is 3.0 or lower, that one oral medicine statement supports uncomplicated extraction at an INR of 3.5, and that some experts accept up to 4.0. These are not contradictory so much as different comfort levels for different settings. The right threshold for you depends on why you take warfarin, how stable your readings are, and how extensive the surgery will be.

Two practical points follow. First, a recent INR result, ideally with your recent trend, is far more useful than a verbal “it’s fine.” Second, the dentist should not adjust your warfarin dose. If a change is needed, it comes from the clinician who manages your anticoagulation.

Eliquis, Xarelto, Pradaxa, and edoxaban

Direct oral anticoagulants (DOACs) include apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), and edoxaban. They do not need INR monitoring, and a normal INR says nothing reassuring about a DOAC.

Should you stop Eliquis or Xarelto before a tooth extraction? Not on your own. For low-risk procedures, the SDCEP guidance recommends treating without interrupting a DOAC. For higher-risk procedures, it advises that the dental team may ask the patient to miss or delay the morning dose before treatment, alongside measures such as early-day scheduling, staging, packing, and suturing. That is a professional protocol decided case by case, not a rule to apply to yourself. The SDCEP quick reference also labels these as conditional recommendations based on very low certainty evidence, which is an honest sign of how limited the data are.

The ADA reaches a similar place. It acknowledges there is no direct evidence from prospective trials comparing strategies, concludes that most patients need no change, and lists physician-advised timing changes or a short interruption as options for higher-risk patients or extensive surgery.

Kidney function deserves a mention. Dabigatran in particular is cleared by the kidneys, so reduced kidney function can prolong its effect. Older age, low body weight, liver disease, previous bleeding, and interacting drugs can also raise bleeding risk. These are the details your dentist will want to see in your records.

Aspirin, clopidogrel, ticagrelor, and prasugrel

For patients on single or dual antiplatelet therapy, SDCEP recommends treating without interruption. The ADA cites a 2020 meta-analysis that found similar bleeding rates with dual therapy, single therapy, and no therapy, and concluded that interrupting dual antiplatelet therapy before minor oral surgery was not advised.

The reason is straightforward. Oral bleeding is visible and usually controllable with pressure, packing, and sutures. A clot in a heart artery or a brain artery is not. Stopping an antithrombotic drug can trade a manageable problem for a dangerous one.

SDCEP specifically advises against interrupting anticoagulant or antiplatelet therapy without direct specialist instruction in patients with prosthetic metal heart valves or coronary stents, anyone treated for a deep vein thrombosis or pulmonary embolism in the last three months, and anyone anticoagulated around a cardioversion. If you have a coronary stent, any change should come in writing from your cardiologist, not from a booking agent, a friend, or an online article.

Do not leave out aspirin because it is “only over the counter.” A daily low-dose aspirin counts.

Cleaning, extraction, implant, and complex-surgery differences

The most useful way to think about bleeding risk is by the size of the wound. There is no universal list, and the categories below are a planning aid rather than a rule, but they reflect how the SDCEP and ADA guidance is applied.

Type of treatment Typical approach for people on blood thinners What affects the plan
Examination, X-rays, cleaning above the gumline, most fillings, crowns, bridges, root canal treatment Usually no change to medication Local anesthetic injections are generally acceptable; the dentist needs to know the drug.
One or a few simple extractions, limited gum treatment, a straightforward single implant Often manageable while continuing medication, with local bleeding control Wound size, operator judgment, recent INR if on warfarin, kidney function, previous bleeding.
Multiple or surgical extractions, flap surgery, several implants, extractions with immediate implants, bone grafting, sinus lift, full-arch surgery Individualized plan, possibly staged, with prescriber input and clinician-directed timing decisions where needed Larger wound, longer procedure, need for stronger hemostasis and a written plan before travel.

Bigger operations create larger wounds, take longer, and are more likely to involve flaps, bone work, and sutures. A bone graft or sinus lift is a good example: it is not just a bigger implant, and it deserves its own conversation about medication. The same is true of staged work such as full-mouth reconstruction, where the recovery period and the sequence of procedures can be planned around your medical needs. Even a single implant is not identical for every patient, which is why the dental implant treatment you are considering should always be discussed with your full medication list in hand.

How dentists control bleeding

Several techniques are used together. They include gentle, atraumatic surgery, limiting or staging the area treated, firm gauze pressure, packing the socket with an absorbable hemostatic material, suturing, and confirming that bleeding has stopped before the patient leaves. Booking surgery early in the day and early in the week leaves time to observe the site and to get help if needed.

Patients should leave with written aftercare instructions and a way to reach the clinic. Tranexamic acid mouthwash is sometimes used as an add-on at the dentist’s discretion, but SDCEP stresses that suturing, packing, and pressure are usually the central measures, so it should not be treated as essential.

For an extensive operation, ask for a written, individualized plan before you fly. A medication plan improvised on the morning of surgery can cause avoidable delay, and in a hotel room far from home, a clear plan is worth far more than a reassuring guess.

Bisphosphonates, denosumab, and jaw healing

Few medication topics cause more worry before dental surgery than bone-strengthening drugs, and few are explained so inconsistently online. The short version: most people who take these drugs for osteoporosis can still have routine dentistry, and many can have extractions and implants, but the planning is more careful than for someone who takes no such drug. People receiving frequent high-dose treatment for cancer are in a different situation altogether.

The concern is a rare condition called medication-related osteonecrosis of the jaw, or MRONJ. In MRONJ, an area of jawbone is exposed in the mouth and does not heal. Bisphosphonates and denosumab slow the cells that break down bone, which protects the skeleton but can also slow the normal remodeling that follows an extraction or implant placement in the jaw.

Osteoporosis treatment versus cancer treatment

The same drug names appear in two very different medical settings, and this is the most important distinction in the whole topic.

  Osteoporosis treatment Cancer-related bone treatment
Purpose Reduce fracture risk Reduce bone complications from bone metastases or multiple myeloma
Examples Alendronate (Fosamax), risedronate (Actonel), ibandronate (Boniva), zoledronic acid (Reclast), denosumab (Prolia) Zoledronic acid (Zometa), denosumab (Xgeva)
Dosing pattern Lower doses, given less intensively, such as one denosumab injection every six months Higher doses given far more often, such as denosumab every four weeks
MRONJ risk Low overall Considerably higher
Elective dental surgery Not automatically ruled out; individualized risk assessment Generally avoided during active treatment unless reviewed with the oncology team

Route alone does not tell the story. The simple rule “intravenous is risky and oral is safe” is misleading, because zoledronic acid is used in both settings. What matters more is the indication, the dose, how often it is given, how long you have taken it, and what else is going on in your mouth and body. When you talk to a dentist, name the exact product, the dose, the schedule, and the reason it was prescribed.

Prolia versus Xgeva

Prolia and Xgeva are both denosumab, which is not a bisphosphonate. It blocks a protein called RANKL that drives bone breakdown. They are used very differently.

According to the Prolia prescribing information, the recommended dose is 60 mg as a single injection once every six months. The Xgeva prescribing information gives 120 mg every four weeks for preventing skeletal complications in people with bone metastases from solid tumors and in people with multiple myeloma. Both labels list osteonecrosis of the jaw as a recognized risk. The Xgeva label recommends an oral examination before starting and advises avoiding invasive dental procedures during treatment.

Does Prolia increase the risk of jaw osteonecrosis? Yes, as a rare, recognized risk, and the figures are covered below. But Prolia has a second feature that matters just as much to dental planning. After denosumab is stopped or a dose is delayed, bone turnover can rebound quickly. The Prolia label warns that fracture risk increases after discontinuation, including the risk of multiple vertebral fractures. This is why delaying a Prolia injection to suit a dental appointment is not a decision to make alone.

What MRONJ is, and how rare it is

The American Association of Oral and Maxillofacial Surgeons (AAOMS) defines MRONJ by three features together: current or previous treatment with an antiresorptive drug (sometimes alongside other drugs that affect immunity or blood vessel growth), exposed bone or bone that can be probed through a fistula in the jaw region for more than eight weeks, and no history of radiation to the jaws or obvious cancer spread to the jaw.

Risk numbers need care, because they describe different things. Three kinds of figure appear in the literature:

  • Overall incidence in osteoporosis patients. AAOMS estimates the risk of MRONJ in osteoporosis patients treated with bisphosphonates at roughly 0.02 to 0.05 percent (its position paper also quotes 0.02 to 0.04 percent in one summary passage, the same range the Australian consensus statement below uses), and at about 0.3 percent for denosumab. These are estimates across everyone treated, whether or not they ever had a tooth removed. An older ADA expert panel put the upper reliable estimate near 0.10 percent for osteoporosis regimens, which shows how estimates vary by era and method.

  • Risk after a specific dental procedure. The March 2026 Healthy Bones Australia consensus statement, endorsed by the Australian Dental Association among other bodies, cites figures of roughly 1 to 2.5 percent for people on osteoporosis therapy who undergo invasive dental procedures. It also notes that these data are variable and lack prospective support. It mentions an Australian retrospective study in high-risk patients, mostly on denosumab, that reported 5.5 percent after extractions.

  • Risk in cancer settings. AAOMS describes the risk as considerably higher in cancer patients than in osteoporosis patients. For zoledronic acid it reports cumulative risk clustering in the low single digits, under 5 percent, but with published ranges from 0 to 18 percent depending on follow-up, which in the studies it reviews runs from one to ten years. For denosumab at cancer doses it reports a range of 0 to 6.9 percent, with most studies under 5 percent. After a tooth extraction specifically, figures for cancer patients exposed to bisphosphonates range from about 1.6 to 14.8 percent across the studies it cites. The Australian statement describes the incidence at cancer doses as roughly a hundred times higher than at osteoporosis doses. Under 5 percent is therefore a common finding, not a ceiling, and any single percentage depends on the drug, the follow-up period, and the clinical setting.

These figures should not be compared directly. They come from different patient populations, different procedures, different follow-up periods, and different study designs, and they answer different questions: how often MRONJ appears in everyone treated, how often it follows a particular procedure, and how often it occurs at cancer-level doses. What they have in common is the direction. Most people on osteoporosis medication never develop MRONJ, and the chance in any one person rises when a bone-invasive procedure is added to long-term treatment. Because the evidence is mostly observational, no figure should be read as a promise for an individual.

Several factors raise concern. They include high-dose or frequent cancer regimens, longer treatment (the ADA flags more than two years as a risk marker, though not a cutoff), active gum or tooth-root infection, extractions and other bone-injuring procedures, and cancer, chemotherapy, antiangiogenic drugs, systemic corticosteroids, diabetes, and smoking. Poorly fitting dentures that traumatize the gums, and inflammation around implants, also matter.

Extractions, implants, grafts, and sinus lifts

Can you get dental implants while taking bisphosphonates? In many cases, with planning. The ADA’s guidance on osteoporosis medications states that routine dental treatment should not be modified solely because of osteoporosis antiresorptive medication, and that regular dental care and good hygiene may be the best way to lower risk. It says antiresorptive therapy does not appear to be a contraindication for implant placement, while stressing that larger, longer-term studies are needed. AAOMS similarly advises that patients considering implants receive informed consent covering the low risk of MRONJ and the possibility of early or late implant failure, because implant data remain conflicting.

In practice, a dentist weighing an extraction or an implant in a patient on osteoporosis treatment looks at the indication, dose, route, and years of exposure, plus infection, steroid use, diabetes, smoking, and the extent of surgery. Careful technique, control of infection, secure closure of the wound, informed consent, and follow-up all carry weight.

Bone grafts and sinus lifts involve more bone manipulation than a single extraction, and there is less evidence for them. They call for a more cautious, individualized assessment before any date is booked, and for a frank discussion of what is and is not known.

For people receiving cancer-dose bisphosphonates or denosumab, the approach is different. Elective extractions, implants, and grafting during active treatment are generally avoided, and any exception is a decision for the dentist or oral surgeon working with the oncology team.

Drug holidays and denosumab rebound

A “drug holiday” is a planned pause in medication, intended to lower the chance of MRONJ before surgery. It sounds sensible, and some websites present it as routine. The evidence does not support that, and the major bodies disagree:

  • The ADA says there is insufficient evidence to recommend a holiday or waiting period for osteoporosis antiresorptives.
  • AAOMS reports that its working group was evenly divided and could not reach a consensus. Where a prescriber and surgical team do choose to suspend denosumab, AAOMS describes surgery roughly three to four months after the last dose with treatment resuming six to eight weeks after surgery, which is one clinician-coordinated option in a contested area and not a patient instruction.
  • The Healthy Bones Australia statement says there is no evidence that treatment breaks reduce MRONJ, and that osteoporosis therapy should not be stopped without the prescriber. It treats stopping denosumab or delaying a dose beyond about four weeks as unsafe, and mentions that some guidelines suggest scheduling an invasive procedure two to four weeks before the next dose so the next injection is not unduly delayed. It adds that this timing has no robust supporting evidence.

The two timing options point in different directions, and that tells you something. The field has not settled, and any plan involving denosumab belongs to your prescriber and surgeon together.

Bisphosphonates behave differently. AAOMS notes that they bind to bone, which denosumab does not, and the Healthy Bones Australia statement finds little evidence that a short bisphosphonate break lowers MRONJ risk. Denosumab’s effect on bone fades within months of the last dose, and that is exactly why delay can trigger rebound bone loss and painful vertebral fractures.

Why a CTX blood test is not a clearance test

You may come across a blood test called serum CTX, a marker of bone turnover, marketed as a way to “clear” a patient for implants. Neither the ADA nor AAOMS supports this. The ADA states that there is no validated method to identify who will develop MRONJ and that evidence for CTX as a predictor is insufficient, and AAOMS says bone turnover markers are not a useful tool for assessing MRONJ risk. A single CTX number cannot give you a green light.

Warning signs and follow-up

Contact your dentist promptly if, after treatment, you notice exposed bone, an extraction site or implant site that is not healing, pain or swelling that persists, drainage or a bad taste, numbness or altered sensation, a fistula, or teeth or implants that become loose without an obvious cause. MRONJ can also appear without any recent procedure, so ongoing dental review matters.

Normal healing and a worrying problem can look similar in the first days. Our guide to dental implant healing stages explains what usually happens month by month, and any slower-than-expected recovery is worth raising with your dentist, particularly if you take one of these medicines.

One last note on timing. For cancer patients, a dental examination and treatment of infection before high-dose therapy starts is valuable. For osteoporosis, AAOMS allows dental optimization to proceed alongside the start of treatment, and good hygiene with regular care remains the central strategy.

DIABETES MEDICATIONS AND DENTAL TREATMENT

Diabetes medications and dental treatment

Diabetes and its general effects on gum health and healing are covered in our article on dental care for patients with diabetes. Here the focus is narrower: how your glucose-lowering medicines interact with the day of treatment.

Should you take diabetes medication before a dental appointment? For routine care under local anesthetic without fasting, patients commonly eat normally and take their scheduled medication as usual. The ADA’s diabetes guidance for dental teams advises confirming that the patient has eaten normally and taken scheduled medication, and notes that morning appointments are advisable. If sedation, fasting, or a long gap before your next meal is expected, the plan changes, and you need individualized instructions from your prescriber and the dental team in advance.

Insulin, sulfonylureas, and missed meals

Insulin and sulfonylureas (for example gliclazide and glipizide) are the drugs most likely to cause low blood sugar if a meal is delayed. Warning signs include sweating, shakiness, a change in mood or behavior, confusion, and in severe cases reduced consciousness. The ADA describes hypoglycemia as a glucose level of 70 mg/dL or lower and describes treating a conscious patient with 15 to 20 grams of oral carbohydrate, then rechecking. If you feel any of these symptoms during treatment, say so immediately.

Long implant appointments and surgery that makes eating difficult afterward are the situations that call for forward planning. A soft diet after surgery may reduce carbohydrate intake, so your diabetes team and dentist should agree beforehand how your medication fits that.

Metformin and ordinary appointments

Metformin alone rarely causes hypoglycemia. The dentist still needs to know about kidney problems, recent illness, fasting, and any sedation plan, but there is no universal rule to skip metformin before a dental visit under local anesthetic.

Semaglutide, tirzepatide, and sedation

GLP-1 receptor agonists and related drugs, such as semaglutide (Ozempic, Wegovy), dulaglutide, and tirzepatide (Mounjaro, Zepbound), slow stomach emptying. That matters when deep sedation or general anesthesia is planned, because a stomach that has not emptied raises the risk of vomiting and inhaling stomach contents. The guidance is aimed at anesthesia and deep sedation, not at routine dentistry under local anesthetic.

For some time, anesthesia teams told patients to stop these drugs a week or more before surgery. That is no longer the default. A multisociety guidance released in October 2024 and summarized by the American Society of Anesthesiologists says most patients should continue GLP-1 drugs before elective surgery. Patients at higher risk, such as those in the dose-escalation phase early in treatment or with nausea, vomiting, or abdominal pain, may need extra precautions. These can include a liquid-only diet for 24 hours beforehand, an ultrasound check of the stomach, a modified anesthetic technique, or sometimes postponement.

So the right answer depends on the type of anesthesia, your dose, how long you have been taking the drug, and your symptoms. If you take one of these medicines and sedation is on the table, tell the team early. Instructions should come from the anesthesia provider, not from a general article like this one.

SGLT2 inhibitors and surgery

SGLT2 inhibitors, including empagliflozin, dapagliflozin, and canagliflozin, carry a specific perioperative risk of ketoacidosis, a dangerous buildup of acids in the blood, which can occur even when blood sugar looks normal. Because of this, the American Diabetes Association’s Standards of Care in Diabetes 2026 recommend holding these drugs for three to four days before elective surgery.

That instruction belongs to surgery involving fasting or significant physiologic stress, and it must be issued by a clinician. It is not a reason to skip tablets before a routine cleaning or a crown, and you should not decide this yourself. If you take an SGLT2 inhibitor and are planning implant surgery under sedation, raise it with your dentist and prescriber early enough to get a plan.

Stable blood sugar supports healing, but no single HbA1c value guarantees or rules out implant success. Your dental and diabetes teams will consider recent glucose patterns, diabetes complications, infection, and how extensive the surgery is.

Steroids, immunosuppressants, and healing

Can steroids affect implant healing? Long-term systemic corticosteroids, taken as tablets or injections rather than inhaled or applied to the skin, can dampen the immune response and affect aspects of wound healing. They are not an automatic barrier to implants, and they should never be stopped abruptly, because that can itself be dangerous. The effect depends on dose, duration, the underlying disease, other medicines, diabetes, smoking, and how extensive the surgery is.

Long-term corticosteroids and adrenal assessment

Long-term steroids can also suppress the body’s own steroid production, a hormonal system called the hypothalamic-pituitary-adrenal axis. In theory, surgical stress could then trigger a shortage of cortisol. In practice, the guidance on “steroid cover” (extra steroid given around surgery) is inconsistent.

A letter in the British Dental Journal notes that patients taking prednisolone 5 mg or more for a month or longer may be at risk of adrenal suppression, yet the risk during dental treatment under local anesthetic is low and the vast majority of such patients are managed safely in primary dental care. It argues for joint review between the dentist and the endocrinologist for patients considered at risk. Confirmed adrenal insufficiency and major invasive surgery deserve advance assessment by the treating clinician. Do not increase, reduce, or skip your steroid on your own.

Methotrexate and antibiotic interactions

Methotrexate is a weekly immunosuppressant used for rheumatoid arthritis, psoriasis, and other conditions. It is not automatically stopped for dental work. Oxford University Hospitals’ rheumatology advice to patients is to continue medication when having dental treatment. Severe infection, kidney function, the extent of surgery, and interacting prescriptions can change that plan.

The interaction that matters most involves antibiotics. The NHS Specialist Pharmacy Service advises avoiding trimethoprim and co-trimoxazole with methotrexate because of the risk of severe bone marrow suppression. It also notes that penicillins such as amoxicillin may reduce methotrexate clearance by the kidneys, so short courses call for caution and monitoring for toxicity. This is a good example of why your full medication list matters before a dentist writes a prescription.

Biologics and transplant medication

Biologic drugs, such as TNF inhibitors and other targeted immune therapies, are used for conditions including rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease. A 2023 review of biologics in oral surgery found that no formal guidance exists for dental and oral surgery. It describes scheduling elective procedures near the end of a dosing interval, when the drug’s immunosuppressive effect is lowest, and treats any interruption as a shared decision with the prescriber. Both infection and disease flare are real risks, and the balance is individual.

Organ and stem cell transplant recipients need extra care. The National Institute of Dental and Craniofacial Research (NIDCR) advises treating active dental disease before a transplant when possible and avoiding non-emergency dental care for at least three months afterward, with the transplant team consulted about infection risk, blood counts, antibiotic needs, and interactions with immunosuppressant drugs.

CANCER MEDICATIONS AND DENTAL TREATMENT

Cancer medications and dental treatment

Dental timing around cancer treatment has been covered in more depth in our article on dental implants after cancer treatment, which explains why no single waiting period applies. This section summarizes the medication-related points only.

Chemotherapy, neutrophils, and platelets

How long after chemotherapy can you have dental treatment? There is no universal interval. Chemotherapy can temporarily lower white blood cells (neutropenia) and platelets (thrombocytopenia) and can inflame the lining of the mouth (mucositis). The effect depends on the drug, dose, cycle, and the person.

A 2025 MASCC/ISOO clinical practice statement, which focuses on patients with blood cancers and CAR T-cell therapy, recommends dental evaluation before treatment starts. Where extractions are needed, it suggests doing them early enough that the socket can heal with a layer of new tissue, estimated at around two to three weeks. It describes bone marrow recovery after chemotherapy as occurring about two to three weeks after the last dose, and warns that thrombocytopenic patients may bleed heavily after either surgical or non-surgical procedures.

The National Cancer Institute (NCI) recommends a dental checkup at least a month before cancer treatment begins when feasible. Urgent cancer treatment should not be delayed for dentistry without agreement from the oncology team. Blood count thresholds for invasive treatment vary by procedure and institution, so recent results are best interpreted by the oncologist together with the dentist.

Antiresorptives and antiangiogenic drugs

Drugs that block the growth of blood vessels in tumors, such as bevacizumab and sunitinib, can contribute to MRONJ risk, particularly alongside cancer-dose bisphosphonates or denosumab. The earlier section on bisphosphonates and denosumab covers the antiresorptive side. In summary, elective implants during active cancer-dose bone-modifying therapy are generally avoided, and any exception is an oncology-coordinated decision. Antiangiogenic drugs do not have a simple class-wide waiting period.

Head and neck radiation versus MRONJ

These two conditions are often confused. Osteoradionecrosis (ORN) follows radiation injury to the jawbone. MRONJ, by definition, occurs without a history of jaw radiation. The 2024 ISOO-MASCC-ASCO guideline on ORN states that a patient with a radiation dose to the jaw of 50 Gy or higher should be considered at risk for ORN, recommends reviewing the radiation plan with particular attention to the dose to the mandible and maxilla before dental extractions, and advises avoiding implants in high-risk zones unless alternatives for restoring function are not possible.

The practical lesson is that “I had radiotherapy” is not enough. What matters is where the beam went and how much radiation each part of the jaw received. If you have had head and neck radiation, the treatment plan or a summary of the dose to your jaws is one of the most useful documents you can bring.

Why survivorship is not an automatic implant exclusion

Cancer history alone does not decide implant candidacy. Current blood counts, ongoing therapy, exposure to bone-modifying or antiangiogenic drugs, radiation field and jaw dose, dry mouth, disease status, and the condition of the site all count for more than the label “cancer survivor.” For some people with a cancer history, implants are a reasonable option after individual assessment. For others, elective surgery will be advised against. That is why a documented oncology summary matters.

OTHER MEDICATIONS THAT AFFECT YOUR MOUTH AND IMPLANTS

Other medications that affect your mouth and implants

Not every medication that matters to a dentist is dramatic. Some quietly change the mouth over months or years, and those changes shape how teeth, crowns, and implants hold up.

Dry mouth and cavity risk

Saliva protects teeth. It washes away food, neutralizes acids, and carries minerals back into enamel. Saliva that turns thick and sticky can be an early warning sign, as our article on viscous saliva and oral health explains. According to the ADA, the most frequent cause of reduced saliva is the use of certain medications, and drugs with anticholinergic effects are common culprits. Antidepressants, antihistamines, blood pressure medicines, diuretics, decongestants, muscle relaxants, and some pain medicines can all contribute, and the more medicines you take, the more likely it is.

Less saliva raises the chance of cavities, particularly at the root surface and around crown margins. It can also make dentures harder to tolerate and make the tissue around implants more vulnerable to inflammation. The ADA lists measures such as brushing with fluoride toothpaste, prescription-strength fluoride, fluoride varnish applied by a dentist, sugar-free gum or candy to stimulate saliva, and regular dental visits. Do not change or stop a medicine yourself because of dry mouth. If it is a problem, tell your dentist, who can build a prevention plan, and your prescriber, who can decide whether any change is sensible. Our guide to long-term dental implant care explains why keeping the tissue around an implant free of inflammation matters so much.

Calcium-channel blockers and gum enlargement

Some blood pressure and heart medicines, the calcium-channel blockers, can cause the gums to overgrow in some people. The dihydropyridine group, which includes nifedipine and amlodipine, is the main concern. A 2024 review of this problem notes that plaque buildup, individual susceptibility, and how long the drug has been taken all shape how severe it becomes.

Enlarged gum tissue makes cleaning harder, can affect the fit of crowns and the accuracy of scans or impressions, and complicates long-term implant maintenance. The review recommends removing plaque and irritants, strengthening home care, and consulting the physician about any change of medication. First-line care is cleaning and periodontal gum treatment. Any medication change is up to the prescriber.

Antidepressants and teeth grinding

Some antidepressants have been linked with bruxism, which is clenching or grinding of the teeth. A 2025 review in The Mental Health Clinician, Management of antidepressant-induced bruxism, reports that SSRIs account for most cases in the published literature, but that the evidence is weak, rests largely on case reports, and does not establish how common the problem is.

The practical advice is simple. If you notice new clenching, jaw pain, headaches, unusual tooth wear, or a chipped crown after starting or changing an antidepressant, tell your dentist. A night guard or other protective measures may help, and your prescriber can weigh the medication question. Our guide to stress and oral health covers grinding, jaw pain, and night guards in more detail. Do not stop an antidepressant on your own.

A final note on evidence. You may read that SSRIs, acid-reducing drugs, or anti-inflammatory painkillers “cause implant failure.” Studies reporting such links are observational, and they are easily confused by the underlying illness, smoking, age, and how consistently people take their medicines. That evidence does not support strong causal claims for patients, so this article focuses on the effects that are better established: dry mouth, bruxism reports, gum enlargement, bleeding, and genuine drug interactions.

Interactions with anesthesia, antibiotics, and pain relief

Dentists prescribe only a few medicines, but they can interact with what you already take. A full list lets the team choose around problems before they happen.

Local anesthetic and epinephrine

Can regular medicines interact with dental anesthesia? Yes, but most local anesthetic interactions are not clinically important at licensed dental doses. The NHS Specialist Pharmacy Service states that clinically significant interactions with local anesthetics are unlikely, with adrenaline (epinephrine) the one component where relevant interactions may be expected.

Epinephrine is added to many dental anesthetics to prolong the numbness and limit bleeding. The same guidance advises a precaution of no more than two epinephrine-containing cartridges for patients taking non-selective beta blockers, such as propranolol, nadolol, sotalol, or timolol, because the combination can raise blood pressure and affect the heart. A similar precaution applies with tricyclic antidepressants, although the guidance says a clinically significant interaction is not expected in most patients at dental doses.

This does not mean “no epinephrine.” Pain and anxiety release the body’s own adrenaline too, so well-controlled anesthesia has benefits. The dentist weighs the dose, injects slowly, avoids injecting into a blood vessel, and considers your heart condition and blood pressure. Tell the team about heart disease, stimulant medicines, and any beta blocker or tricyclic antidepressant you use.

Sedation interactions

Sedation is not a single thing. Oral anxiety-relief medicine, moderate sedation, deep sedation, and general anesthesia carry very different interaction profiles. Benzodiazepines, opioids, gabapentinoids, sleeping tablets, sedating antihistamines, and alcohol can all add to the effects of sedatives, including slower breathing. Anyone providing sedation needs your complete list of medicines and substances, including the time of the last dose, and should be the one to give you instructions about eating, drinking, and your regular medication that day. If you plan to travel specifically for treatment under sedation, ask early which type will be used.

Warfarin and antibiotics

For warfarin users, antibiotics are the highest-yield interaction. Infection and antibiotics can both raise the INR. A review in The Journal of Family Practice lists trimethoprim-sulfamethoxazole, metronidazole, fluoroquinolones such as ciprofloxacin and levofloxacin, macrolides such as clarithromycin and azithromycin, and the antifungal fluconazole among the antibiotics and antifungals most likely to interfere with warfarin. The SDCEP guidance on interactions with drugs prescribed by dentists says that an antibiotic should not be withheld if it is clinically appropriate, but the patient should be told that the INR might be increased, and that miconazole should be avoided with warfarin. It also notes a risk of interaction between any DOAC and a macrolide antibiotic. If an antibiotic is needed, the clinician managing your anticoagulation may ask for an extra INR check.

Antibiotics are not a safety net that prevents jaw problems or implant failure. Whether you need one, and which, depends on your health and the procedure, and the evidence for routine antibiotic regimens varies.

NSAIDs, acetaminophen, opioids, and antidepressants

Which pain reliever is safest after an extraction if you take a blood thinner? There is no single answer, and the dentist’s instructions for your case take priority. But the pattern is consistent.

Anti-inflammatory drugs such as ibuprofen and naproxen affect platelets and can irritate the stomach lining. The Anticoagulation Forum reports that a 2020 meta-analysis found a nearly twofold increase in gastrointestinal bleeding when warfarin is combined with an NSAID, and it discourages the combination with oral anticoagulants. SDCEP likewise discourages NSAIDs for patients with vascular disease because of their antiplatelet effect, and says that if one is required, the course should be as short as possible and stomach protection considered.

Acetaminophen (paracetamol) is often preferred for people on anticoagulants, but it is not free of interactions. In a small randomized trial in patients on stable warfarin, regular high-dose acetaminophen raised the INR within a week, so repeated use matters. Total daily intake must count every combination product, and liver disease or heavy alcohol use changes the calculation. Follow the dentist’s individualized instructions rather than a general schedule.

Some opioid painkillers interact with antidepressants. The New Zealand regulator Medsafe warns that tramadol, pethidine (meperidine), and dextromethorphan carry a high risk of serotonin syndrome when combined with serotonergic antidepressants. Serotonin syndrome is rare but can be life-threatening. Opioids also add to the breathing effects of benzodiazepines and other sedatives. These are reasons for a full medication review before any after-surgery prescription is written.

Preparing for dental treatment in Thailand

Medication planning is easier when it starts before the flight. General travel logistics are covered in our dental tourism safety checklist, which also suggests planning the first days of your trip for rest rather than packed sightseeing. This section covers the medication-specific parts.

What to send before you travel

Send your dental team the following, ideally in writing and well ahead of your appointment:

  • Every medicine you take or recently stopped, including prescription drugs, over-the-counter products, aspirin and anti-inflammatories, vitamins, herbal products, injections, and infusions.
  • For each one, the generic and brand name, strength, dose, schedule, the reason you take it, when you started, when you last took it, and your prescriber’s contact details.
  • Allergies and any previous reactions, especially bleeding, low blood sugar, infection, delayed healing, anesthesia problems, or jaw osteonecrosis.
  • Relevant records, depending on your situation: recent INR readings if you take warfarin; recent blood counts during or after chemotherapy; a diabetes summary with recent HbA1c and glucose patterns; the dates, doses, and product names for osteoporosis or cancer bone injections, including the date of the last one; head and neck radiation plans and jaw dose; and any transplant or specialist summary.
  • The procedure you are planning and the type of anesthesia you expect. Medication instructions for a cleaning cannot simply be reused for sedation or for multiple extractions, full-arch surgery, or a sinus graft.

Do not forget recently stopped drugs and infusions, which ordinary medication lists often omit. And if you realize after treatment that you forgot to mention a medicine, tell the dental team straight away. Depending on the drug and procedure, it may change bleeding advice, antibiotic or pain medicine choices, or follow-up.

Prescriptions, packaging, and Thai FDA rules

Carry enough medicine for the trip plus a reasonable buffer for delays, in original labeled packaging and preferably in your hand luggage. Bring a prescription or a doctor’s letter that uses generic names, because the same brand may not be sold in Thailand.

Some prescription medicines are controlled in Thailand as narcotics or psychotropic substances, and the rules depend on the active ingredient, not the brand. According to the Thai FDA’s guidance for travelers, travelers under treatment may carry up to a 90-day prescribed supply of Schedule II or III narcotic medication, but only with an FDA permit applied for at least 15 days before travel. Schedule II to IV psychotropic substances are allowed for up to 30 days with a prescription or certificate from the prescribing doctor, and a 31 to 90 day supply requires a permit. The page states that these rules took effect on September 21, 2024. Rules can change, and older embassy or travel-blog summaries may be out of date, so check the current official guidance for your exact ingredient before you travel.

Recovery time and follow-up at home

Do not book major surgery immediately before your return flight. Leave time to review bleeding, swelling, how well you are tolerating your medicines, and any early infection or wound problem. Our guide on flying after dental surgery explains that timing depends on the procedure and that your treating dentist must give individual clearance.

Also decide, before you leave home, who will follow up with you in your own country, especially after staged implants, grafts, full-arch treatment, or if you have a complex medical history. Take a procedure summary, implant details if relevant, your prescriptions, and emergency instructions with you when you go home.

FREQUENTLY ASKED QUESTIONS ABOUT MEDICATIONS AND DENTAL TREATMENT

Frequently asked questions about medications and dental treatment

Can I have a tooth extracted while taking blood thinners?

Often yes. Most uncomplicated extractions can be done without stopping the medicine once the drug, the INR where relevant, the procedure, and the plan for controlling bleeding are assessed. Extensive or complex surgery, such as surgical wisdom tooth removal or multiple extractions, needs individualized planning. Do not stop a blood thinner on your own.

Should I stop Eliquis or Xarelto before dental treatment?

Not on your own. Low-risk procedures generally proceed without interruption. For higher-risk surgery, the dental team and your prescriber may direct a missed or delayed dose or another plan. That decision depends on the procedure, your kidney function, and why you take the drug.

Is implant surgery safe while taking warfarin?

It can be, particularly for limited surgery with a recent acceptable INR and good local bleeding control. Multiple implants, simultaneous extractions, grafting, or full-arch surgery need more detailed planning. The SDCEP guidance uses an INR below 4 for invasive outpatient care without interrupting warfarin, while some other sources are more conservative.

Can I get dental implants while taking bisphosphonates?

Osteoporosis-dose treatment is not an automatic contraindication, but the indication, dose, route, duration, infection, steroid use, and extent of surgery matter. Informed consent should cover the low risk of MRONJ and implant failure. Active high-dose cancer treatment is a substantially different, higher-risk context.

Does Prolia increase the risk of jaw osteonecrosis?

Yes, as a rare recognized risk. AAOMS estimates the overall risk in osteoporosis treatment with denosumab at up to about 0.3 percent, and individual risk changes with duration, infection, extractions, other illnesses, and earlier bisphosphonate use. Do not delay or skip Prolia for dental reasons without your prescriber, because of the rebound fracture risk.

Is a dental cleaning safe with osteoporosis medication?

Generally yes. The ADA advises against modifying routine dental treatment solely because of osteoporosis antiresorptive medication. Preventive care may also lower the chance that you will need an extraction later.

How long after chemotherapy can I have dental treatment?

There is no universal interval. Bone marrow recovery often occurs around two to three weeks after the last dose, but current blood counts, the healing of the mouth lining, any infection, your regimen, and your oncologist’s advice decide the timing.

Can steroids like prednisone delay implant healing?

Long-term systemic steroids can affect immune response and wound healing, but the risk depends on dose, duration, underlying disease, other medicines, diabetes, smoking, and the size of the operation. They are not an automatic barrier to implants and should never be stopped abruptly.

Should I take insulin or other diabetes medication before a dental appointment?

For routine care without fasting, patients commonly eat and take scheduled medicine as usual. If sedation, fasting, or delayed meals are expected, get individualized instructions in advance, because insulin and sulfonylureas can cause low blood sugar and other drug classes have their own surgical considerations.

Does semaglutide or tirzepatide affect dental sedation?

It can matter for deep sedation or general anesthesia, because these drugs slow stomach emptying. Current multisociety guidance allows most patients to continue them, with extra precautions for higher-risk patients. Tell the sedation provider about the drug, the dose, and any nausea or vomiting.

What if I forgot to mention a medication?

Tell the dental team immediately, even after treatment. Depending on the drug, the procedure, and the anesthesia, timely disclosure can change bleeding advice, antibiotic and pain relief choices, monitoring, and follow-up.

Which records should I bring to Thailand?

Bring your medication list with prescriber contacts, plus the records relevant to you: recent INR or blood counts, diabetes information, osteoporosis or cancer injection history, an oncology summary, and any head and neck radiation plan. Bring prescriptions and any Thai FDA permit required for controlled medication.

Summary: disclose early, coordinate care, and plan individually

The central message of this guide is simple. Medications rarely make dentistry unsafe, but they do change how it should be planned. Tell the dental team about everything you take, including aspirin, supplements, injections, and anything you stopped recently. Expect questions about the exact product, dose, and timing, not just the category.

For routine care, little may change. For surgery, the plan may involve your own physician, specialist, or oncologist, and sometimes a staged approach. In that process, guidelines do not always agree, and honest dentists will say so. Never stop, delay, or change a prescribed medicine on your own, and treat any answer that claims one blood test or one rule clears everyone with suspicion. Individual assessment matters more than any general article, including this one.

If you are considering dental implants in Bangkok or other treatment at Thantakit, send us an enquiry before you travel. Share your medical history, your current medications, and any relevant records, such as recent test results, specialist letters, and details of bone or cancer treatment. The enquiry form accepts attachments, including PDF, Word, and image files. That lets the dental team review your situation, tell you what further information they may need, and discuss a treatment plan with you before you commit to flights and dates.

Our three steps for planning your visit explain how the process works, from your first enquiry to confirming your appointment dates.

References

  1. American Dental Association, Oral Anticoagulant and Antiplatelet Medications and Dental Procedures. https://www.ada.org/resources/ada-library/oral-health-topics/oral-anticoagulant-and-antiplatelet-medications-and-dental-procedures
  2. Felix J, Chaban P, Ouanounou A. Dental Management of Patients Undergoing Antithrombotic Therapy. J Can Dent Assoc 2020;86:k17. https://jcda.ca/k17
  3. SDCEP, Management of Dental Patients Taking Anticoagulants or Antiplatelet Drugs, Quick Reference Guide, 2nd edition (March 2022). https://www.sdcep.org.uk/media/33nfexkn/sdcep-anticoagulants-quick-reference-guide-2nd-edition.pdf
  4. SDCEP, Interactions with drugs prescribed by dentists. https://companion.sdcep.org.uk/management-of-dental-patients-taking-anticoagulants-or-antiplatelet-drugs/flowcharts-and-tools/interactions-with-drugs-prescribed-by-dentists/
  5. Onysko M, Holcomb N, Hornecker J. Antibiotic interactions: Answers to 4 common questions. J Fam Pract 2016;65(7):442-448. https://mdedge.com/content/antibiotic-interactions-answers-4-common-questions
  6. AAOMS, Medication-Related Osteonecrosis of the Jaw: 2022 Update. https://aaoms.org/wp-content/uploads/2024/03/mronj_position_paper.pdf
  7. Healthy Bones Australia, Consensus Statement: Medication-Related Osteonecrosis of the Jaw (MRONJ) and Osteoporosis, 1st edition (March 2026). https://healthybonesaustralia.org.au/wp-content/uploads/2026/03/hba-mronj-guideline-24-march-2026.pdf
  8. American Dental Association, Osteoporosis Medications: Osteonecrosis of the Jaw. https://www.ada.org/resources/ada-library/oral-health-topics/osteoporosis-medications
  9. U.S. FDA, Prolia (denosumab) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125320s216lbl.pdf
  10. U.S. FDA, Xgeva (denosumab) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125320s203lbl.pdf
  11. American Dental Association, Diabetes. https://www.ada.org/resources/ada-library/oral-health-topics/diabetes
  12. American Society of Anesthesiologists, New Multi-Society GLP-1 Clinical Practice Guidance Released (October 2024). https://www.asahq.org/about-asa/newsroom/news-releases/2024/10/new-multi-society-glp-1-guidance
  13. American Diabetes Association, 16. Diabetes Care in the Hospital: Standards of Care in Diabetes 2026. Diabetes Care 2026;49(Suppl 1):S339. https://diabetesjournals.org/care/article/49/Supplement_1/S339/163925/16-Diabetes-Care-in-the-Hospital-Standards-of-Care
  14. Gaw G, Wemyss C, Goodall C. Steroid cover. Br Dent J 2021;231:604. https://www.nature.com/articles/s41415-021-3689-1
  15. Oxford University Hospitals, Rheumatology patient advice: Medication. https://www.ouh.nhs.uk/rheumatology/information/patients/advice/medication/
  16. NHS Specialist Pharmacy Service, Managing interactions with methotrexate. https://sps.nhs.uk/articles/managing-interactions-with-methotrexate/
  17. Management of biologics in oral surgery. J Oral Med Oral Surg 2023;29:28. https://www.jomos.org/articles/mbcb/full_html/2023/03/mbcb230091/mbcb230091.html
  18. NIDCR, Dental Management of the Organ or Stem Cell Transplant Patient. https://www.nidcr.nih.gov/sites/default/files/2022-12/dental-management-organ-stem-cell-transplant.pdf
  19. MASCC/ISOO Clinical Practice Statement: dental evaluation and management prior to treatment for hematologic malignancies and CAR T-cell therapy. Support Care Cancer 2025;33:853. https://link.springer.com/article/10.1007/s00520-025-09845-4
  20. National Cancer Institute, Oral Complications of Cancer Therapies (patient version). https://www.cancer.gov/about-cancer/treatment/side-effects/mouth-throat/oral-complications-pdq
  21. ASCO, ISOO-MASCC-ASCO Guideline on Osteoradionecrosis, summary table (2024). https://society.asco.org/sites/new-www.asco.org/files/content-files/practice-and-guidelines/documents/2024-ORN-Summary-Table.pdf
  22. American Dental Association, Xerostomia (Dry Mouth). https://www.ada.org/resources/ada-library/oral-health-topics/xerostomia
  23. Efe, Colak, Buduneli. Calcium Channel Blockers-Induced Gingival Enlargements: Pathogenic Mechanisms, Clinical Findings, and Management. Curr Oral Health Rep 2024. https://link.springer.com/article/10.1007/s40496-024-00388-x
  24. Management of antidepressant-induced bruxism. The Mental Health Clinician 2025;15(3). https://mhc.kglmeridian.com/view/journals/mhcl/15/3/article-p147.xml
  25. NHS Specialist Pharmacy Service, Managing interactions with local anaesthetics in dentistry. https://sps.nhs.uk/articles/managing-interactions-with-local-anaesthetics-in-dentistry/
  26. Anticoagulation Forum, Clinical FAQ: Drug-Drug Interactions, NSAIDs and OACs. https://acforum.org/web/resource_files/1746707838-8757.pdf
  27. Mahé I, Bertrand N, Drouet L, et al. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study. Haematologica 2006;91(12):1621-1627. https://haematologica.org/article/view/4235
  28. Medsafe (New Zealand), Opioids and serotonergic medicines: risk of serotonin syndrome (September 2022). https://www.medsafe.govt.nz/profs/PUArticles/September2022/Opioids-and-serotonergic%20medicines-risk-of-serotonin-syndrome.html
  29. Thai FDA, Guidance for travelers under treatment carrying personal medications containing narcotic drugs or psychotropic substances. https://en.fda.moph.go.th/entrepreneurs-narcotic-drugs-and-psychotropic-substances/guidance-for-travelers-under-treatment-carrying-01
Appointment Make an appointment